Abacus Global Management Reports Second Quarter 2025 Results
Abacus Global Management (NASDAQ: ABL) reported outstanding Q2 2025 results with total revenue nearly doubling to $56.2 million, up 93% year-over-year. The company achieved GAAP net income of $17.6 million and Adjusted EBITDA growth of 89% to $31.5 million.
Key highlights include $123.1 million in Longevity Funds capital inflows, origination capital deployment of $121.8 million, and a portfolio of 600 policies. The company announced a $20 million share repurchase program and raised its full-year 2025 Adjusted net income guidance to $74-80 million, representing 59-72% growth.
Post-quarter, Abacus completed its warrant exchange offer, resulting in approximately 102.6 million shares outstanding, representing a 5% increase.
Abacus Global Management (NASDAQ: ABL) ha riportato risultati eccezionali nel secondo trimestre 2025, con un fatturato totale quasi raddoppiato a 56,2 milioni di dollari, in crescita del 93% su base annua. L'azienda ha registrato un utile netto GAAP di 17,6 milioni di dollari e una crescita dell'EBITDA rettificato dell'89%, raggiungendo 31,5 milioni di dollari.
I punti salienti includono 123,1 milioni di dollari di capitali in entrata nei Longevity Funds, un impiego di capitale per l'origine di 121,8 milioni di dollari e un portafoglio di 600 polizze. L'azienda ha annunciato un programma di riacquisto di azioni da 20 milioni di dollari e ha aumentato le previsioni di utile netto rettificato per l'intero 2025 a 74-80 milioni di dollari, con una crescita prevista tra il 59% e il 72%.
Dopo la chiusura del trimestre, Abacus ha completato l'offerta di scambio dei warrant, portando il numero di azioni in circolazione a circa 102,6 milioni, con un aumento del 5%.
Abacus Global Management (NASDAQ: ABL) reportó resultados sobresalientes en el segundo trimestre de 2025, con ingresos totales que casi se duplicaron hasta 56,2 millones de dólares, un aumento del 93% interanual. La compañía logró un ingreso neto GAAP de 17,6 millones de dólares y un crecimiento del EBITDA ajustado del 89%, alcanzando 31,5 millones de dólares.
Los aspectos destacados incluyen 123,1 millones de dólares en entradas de capital para los Fondos de Longevidad, un despliegue de capital de originación de 121,8 millones de dólares y una cartera de 600 pólizas. La empresa anunció un programa de recompra de acciones por 20 millones de dólares y elevó su previsión de ingreso neto ajustado para todo 2025 a 74-80 millones de dólares, lo que representa un crecimiento del 59% al 72%.
Tras el trimestre, Abacus completó su oferta de intercambio de warrants, resultando en aproximadamente 102,6 millones de acciones en circulación, lo que representa un aumento del 5%.
Abacus Global Management (NASDAQ: ABL)는 2025년 2분기에 총 매출이 거의 두 배로 증가하여 5,620만 달러를 기록하며 전년 대비 93% 성장한 뛰어난 실적을 보고했습니다. 회사는 GAAP 순이익 1,760만 달러와 조정 EBITDA가 89% 성장하여 3,150만 달러를 달성했습니다.
주요 내용으로는 장수펀드 자본 유입 1억 2,310만 달러, 원천 자본 배치 1억 2,180만 달러, 600건의 보험 계약 포트폴리오가 포함됩니다. 회사는 2,000만 달러 규모의 자사주 매입 프로그램을 발표했으며, 2025년 전체 조정 순이익 전망치를 7,400만~8,000만 달러로 상향 조정하여 59~72%의 성장을 예상하고 있습니다.
분기 종료 후, Abacus는 워런트 교환 제안을 완료하여 약 1억 2,600만 주의 발행 주식 수를 기록하며 5% 증가했습니다.
Abacus Global Management (NASDAQ : ABL) a annoncé des résultats exceptionnels pour le deuxième trimestre 2025, avec un chiffre d'affaires total ayant presque doublé pour atteindre 56,2 millions de dollars, soit une hausse de 93 % en glissement annuel. La société a enregistré un résultat net GAAP de 17,6 millions de dollars et une croissance de l'EBITDA ajusté de 89 %, atteignant 31,5 millions de dollars.
Les points clés incluent 123,1 millions de dollars de flux de capitaux dans les fonds Longevity, un déploiement de capital d'origine de 121,8 millions de dollars et un portefeuille de 600 polices. La société a annoncé un programme de rachat d'actions de 20 millions de dollars et a relevé ses prévisions de résultat net ajusté pour l'ensemble de l'année 2025 à 74-80 millions de dollars, soit une croissance de 59 à 72 %.
Après la fin du trimestre, Abacus a finalisé son offre d'échange de bons de souscription, ce qui a porté le nombre d'actions en circulation à environ 102,6 millions, soit une augmentation de 5 %.
Abacus Global Management (NASDAQ: ABL) meldete herausragende Ergebnisse für das zweite Quartal 2025 mit einem Gesamtumsatz, der sich fast verdoppelte und 56,2 Millionen US-Dollar erreichte, was einem Anstieg von 93 % im Jahresvergleich entspricht. Das Unternehmen erzielte einen GAAP-Nettogewinn von 17,6 Millionen US-Dollar und ein bereinigtes EBITDA-Wachstum von 89 % auf 31,5 Millionen US-Dollar.
Zu den wichtigsten Highlights zählen Kapitalzuflüsse von 123,1 Millionen US-Dollar in Longevity-Fonds, ein Kapitaleinsatz für die Originierung von 121,8 Millionen US-Dollar und ein Portfolio von 600 Policen. Das Unternehmen kündigte ein Aktienrückkaufprogramm in Höhe von 20 Millionen US-Dollar an und hob seine Prognose für das bereinigte Nettoergebnis im Gesamtjahr 2025 auf 74-80 Millionen US-Dollar an, was einem Wachstum von 59-72 % entspricht.
Nach Quartalsende hat Abacus sein Optionsscheintauschangebot abgeschlossen, was zu etwa 102,6 Millionen ausstehenden Aktien führte, was einer Steigerung von 5 % entspricht.
- Total revenue surged 93% year-over-year to $56.2 million
- GAAP net income grew significantly to $17.6 million from $0.7 million YoY
- Adjusted EBITDA increased 89% to $31.5 million with 56.1% margin
- Strong capital position with $74.8 million in cash and cash equivalents
- Raised full-year 2025 guidance, projecting 59-72% growth in Adjusted net income
- Announced new $20 million share repurchase program
- Successful warrant exchange offer completion, eliminating warrant overhang
- Adjusted EBITDA margin slightly decreased to 56.1% from 57.5% YoY
- 5% share dilution from warrant exchange completion
- Substantial debt level of $357 million against $387.3 million in policy assets
Insights
Abacus delivered exceptional Q2 with 93% revenue growth, raised 2025 outlook, and strong operational metrics indicating sustainable profitability trajectory.
Abacus Global Management's Q2 results demonstrate exceptional growth momentum, with total revenue nearly doubling year-over-year to
The profitability metrics tell an impressive story. Adjusted EBITDA surged
The fundamental growth drivers appear sustainable. Policy acquisition increased from 458 to 600 year-over-year, while capital deployment rose to
Balance sheet strength is evident with
Most telling is management's raised full-year guidance for adjusted net income to
- Second Quarter 2025 Total Revenue Nearly Doubles Year-over-Year to
- Longevity Funds Attracted
- GAAP Net Income of
- Adjusted Net Income Grew
- Adjusted EBITDA Grew
~ Raises Full Year 2025 Outlook ~
ORLANDO, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today reported results for the second quarter ended June 30, 2025.
“We delivered another excellent quarter of record profitable growth in the second quarter of 2025, nearly doubling total revenue and adjusted earnings year-over-year, enabling us to raise our full year outlook for adjusted earnings,” said Jay Jackson, Chief Executive Officer of Abacus. “Our strong performance was driven by robust demand for policyholder liquidity, as well as increased inflows for our new asset management offerings. Our differentiated origination-focused business model, serving both liquidity-seeking consumers and yield-seeking investors, enables us to capture true market value in any macro environment. With our greater scale and capabilities, our ability to consistently execute on our strategic growth initiatives and our expanding brand recognition, we remain steadfast in our mission to establish Abacus as the leading alternative asset and wealth management company.”
Second Quarter 2025 Highlights
- Total revenue for the second quarter grew
93% to$56.2 million , compared to$29.1 million in the prior-year period. The increase was primarily driven by higher revenues from Life Solutions as well as a full quarter of asset management fees from the acquisitions that were completed in the fourth quarter of 2024. - Origination capital deployment for the second quarter of 2025 was
$121.8 million , compared to$104.7 million in the prior-year period; number of policies held as of the end of the second quarter of 2025 stood at 600, compared to 458 in the prior-year period. - GAAP net income attributable to shareholders for the second quarter of 2025 of
$17.6 million grew$16.9 million compared to net income of$0.7 million in the prior-year period. The increase was primarily driven by higher revenues and a non-recurring$4.2 million gain on change in fair value of warrant liability, partially offset by increased operating expenses. - Adjusted net income (a non-GAAP financial measure) for the second quarter of 2025 grew
87% to$21.9 million , compared to$11.7 million in the prior-year period. Adjusted diluted earnings per share for the second quarter of 2025 was$0.22 , compared to$0.17 in the prior-year period. - Adjusted EBITDA (a non-GAAP financial measure) for the second quarter of 2025 increased
89% to$31.5 million , compared to$16.7 million in the prior-year period. Adjusted EBITDA margin (a non-GAAP financial measure) for the second quarter of 2025 was56.1% , compared to57.5% in the prior-year period. - Adjusted Annualized return on invested capital (ROIC) (a non-GAAP financial measure) for the second quarter of 2025 was
22% . - Annualized Return on equity (ROE) (a non-GAAP financial measure) for the second quarter of 2025 was
21% . - Company introduces supplemental KPIs to provide greater insight into the Company’s operational performance:
- Annualized Turnover Ratio (a non-GAAP financial measure) for the second quarter of 2025 was 2.3x.
- Average Realized Gain (a non-GAAP financial measure) for the second quarter of 2025 was
26.3% .
- Announced a newly authorized
$20 million Share Repurchase program, approved by the Board effective June 5, 2025. - Hosted Investor Day and Longevity Summit at Nasdaq in New York City on June 12, 2025. During the event the Company announced the public launch of a new corporate-focused commercial campaign. A replay of the event is accessible here.
Liquidity and Capital
As of June 30, 2025, the Company had cash and cash equivalents of
2025 Outlook
Driven by strong second quarter performance, the Company is raising its full year 2025 outlook for Adjusted net income to between
For a definition of Adjusted net income, see “Non-GAAP Financial Information” below.
Subsequent Events
On July 30, 2025, the Company eliminated the overhang of its warrants, announcing the completion of its previously announced exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) relating to its outstanding warrants. As a result of the completion of the Offer and the Post-Offer Exchange, no warrants will remain outstanding. Accordingly, the public warrants are expected to be suspended from trading on the Nasdaq as of the close of business on August 14, 2025, and will be delisted.
Following completion of the Offer, there are approximately 102,050,981 shares of common stock outstanding (an increase of approximately
Webcast and Conference Call
A webcast and conference call to discuss the Company’s results will be held today beginning at 5:00 p.m. (Eastern Time). A live webcast of the conference call will be available on Abacus’ investor relations website at ir.abacuslife.com. The dial-in number for the conference call is (844) 826-3033 (toll-free) or (412) 317-5185 (international). Please dial the number 10 minutes prior to the scheduled start time.
A webcast replay of the call will be available at ir.abacusgm.com for one year following the call.
Non-GAAP Financial Information
Adjusted Net Income, a non-GAAP financial measure, is defined as net income (loss) attributable to Abacus adjusted for non-controlling interest income, amortization, change in fair value of warrants and non-cash stock-based compensation and the related tax effect of those adjustments. Management believes that Adjusted Net Income is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to business performance. A reconciliation of Adjusted Net Income to Net income attributable to Abacus, the most directly comparable GAAP measure, appears below.
The Company is unable to provide a comparable FY 2025 outlook for, or a reconciliation to net income because it cannot provide a meaningful or accurate calculation or estimation of certain reconciling items without unreasonable effort. Its inability to do so is due to the inherent difficulty in forecasting the timing of items that have not yet occurred and quantifying certain amounts that are necessary for such reconciliation, including variations in effective tax rate, expenses to be incurred for acquisition activities, and other one-time or exceptional items.
Adjusted EBITDA, a non-GAAP financial measure, is defined as net income (loss) attributable to Abacus adjusted for depreciation expense, amortization, interest expense, income tax and other non-cash and certain non-recurring items that in our judgement significantly impact the period-over-period assessment of performance and operating results that do not directly relate to business performance within Abacus’ control. A reconciliation of Adjusted EBITDA to Net income attributable to Abacus Life, the most directly comparable GAAP measure, appears below.
Adjusted EBITDA margin, a non-GAAP financial measure, is defined as Adjusted EBITDA divided by Total revenues. A reconciliation of Adjusted EBITDA margin to Net income margin, the most directly comparable GAAP measure, appears below.
Annualized return on invested capital (ROIC), a non-GAAP financial measure, is defined as Adjusted net income for the quarter divided by the result of Total Assets less Intangible assets, net, Goodwill and Current Liabilities multiplied by four. ROIC is not a measure of financial performance under GAAP. We believe ROIC should be considered in addition to, not as a substitute for, operating income or loss, net income or loss, cash flows provided by or used in operating, investing and financing activities or other income statement or cash flow statement line items reported in accordance with GAAP.
Annualized return on equity (ROE), a non-GAAP financial measure, is defined as Adjusted net income divided by total shareholder equity multiplied by four. ROE is not a measure of financial performance under GAAP. We believe ROE should be considered in addition to, not as a substitute for, operating income or loss, net income or loss, cash flows provided by or used in operating, investing and financing activities or other income statement or cash flow statement line items reported in accordance with GAAP. The below table presents our calculation of ROE.
Forward-Looking Statements
All statements in this press release (and oral statements made regarding the subjects of this press release) other than historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of uncertainties and factors that could cause actual results to differ materially from such statements, many of which are outside the control of Abacus. Forward-looking information includes but is not limited to statements regarding: Abacus’s financial and operational outlook; Abacus’s operational and financial strategies, including planned growth initiatives and the benefits thereof, Abacus’s ability to successfully effect those strategies, and the expected results therefrom. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “expect,” “intend,” “anticipate,” “goals,” “prospects,” “will,” “would,” “will continue,” “will likely result,” and similar expressions (including the negative versions of such words or expressions).
While Abacus believes that the assumptions concerning future events are reasonable, it cautions that there are inherent difficulties in predicting certain important factors that could impact the future performance or results of its business. The factors that could cause results to differ materially from those indicated by such forward-looking statements include, but are not limited to: the fact that Abacus’s loss reserves are bases on estimates and may be inadequate to cover its actual losses; the failure to properly price Abacus’s insurance policies; the geographic concentration of Abacus’s business; the cyclical nature of Abacus’s industry; the impact of regulation on Abacus’s business; the effects of competition on Abacus’s business; the failure of Abacus’s relationships with independent agencies; the failure to meet Abacus’s investment objectives; the inability to raise capital on favorable terms or at all; the effects of acts of terrorism; and the effectiveness of Abacus’s control environment, including the identification of control deficiencies.
These forward-looking statements are also affected by the risk factors, forward-looking statements and challenges and uncertainties set forth in documents filed by Abacus with the U.S. Securities and Exchange Commission from time to time, including the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and subsequent periodic reports. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Abacus cautions you not to place undue reliance on the forward-looking statements contained in this press release. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Abacus assumes no obligation and, except as required by law, does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Abacus does not give any assurance that it will achieve its expectations.
About Abacus
Abacus Global Management (NASDAQ: ABL) is a leading financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. With a focus on longevity-based assets and personalized financial planning, Abacus leverages proprietary data analytics and decades of industry expertise to deliver innovative solutions that optimize financial outcomes for individuals and institutions worldwide.
Contacts :
Investor Relations
Robert F. Phillips – SVP Investor Relations and Corporate Affairs
rob@abacusgm.com
(321) 290-1198
David Jackson – Managing Director of Investor Relations
david@abacusgm.com
(321) 299-0716
Abacus Global Management Public Relations
press@abacusgm.com
ABACUS GLOBAL MANAGEMENT, INC. CONSOLIDATED BALANCE SHEET | |||||||
June 30, 2025 (unaudited) | December 31, 2024 | ||||||
ASSETS | |||||||
CURRENT ASSETS: | |||||||
Cash and cash equivalents | $ | 74,836,871 | $ | 131,944,282 | |||
Accounts receivable | 14,512,827 | 15,785,531 | |||||
Accounts receivable, related party | 10,989,251 | 7,113,369 | |||||
Income taxes receivable | 145,839 | 2,099,673 | |||||
Prepaid expenses and other current assets | 5,435,222 | 2,621,791 | |||||
Total current assets | 105,920,010 | 159,564,646 | |||||
Property and equipment, net | 1,517,845 | 1,025,066 | |||||
Intangible assets, net | 71,392,006 | 79,786,793 | |||||
Goodwill | 238,921,108 | 238,296,200 | |||||
Operating right-of-use assets | 4,867,682 | 4,722,573 | |||||
Management and performance fee receivable, related party | 14,501,482 | 13,379,301 | |||||
Life settlement policies, at fair value | 386,144,698 | 370,398,447 | |||||
Life settlement policies, at cost | 1,109,808 | 1,083,977 | |||||
Available-for-sale securities, at fair value | 3,287,463 | 2,205,904 | |||||
Other investments | 9,850,000 | 1,850,000 | |||||
Other assets | 10,845,818 | 1,851,845 | |||||
TOTAL ASSETS | $ | 848,357,920 | $ | 874,164,752 | |||
LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS' EQUITY | |||||||
CURRENT LIABILITIES: | |||||||
Current portion of long-term debt, at fair value | $ | 117,869,504 | $ | 37,430,336 | |||
Current portion of long-term debt | 1,000,000 | 1,000,000 | |||||
Accrued expenses | 5,316,412 | 6,139,472 | |||||
Current operating lease liabilities | 646,851 | 515,597 | |||||
Contract liabilities, deposits on pending settlements | 45,869 | 2,473,543 | |||||
Accrued transaction costs | 879,329 | 483,206 | |||||
Other current liabilities | 12,143,344 | 14,423,925 | |||||
Income taxes payable | 2,276,726 | — | |||||
Total current liabilities | 140,178,035 | 62,466,079 | |||||
Long-term debt, net | 224,895,561 | 224,742,029 | |||||
Long-term debt, at fair value | — | 105,120,100 | |||||
Long-term debt, related party | 13,296,214 | 12,525,635 | |||||
Retrocession fees payable | 5,361,714 | 5,312,214 | |||||
Noncurrent operating lease liabilities | 4,713,328 | 4,580,158 | |||||
Deferred tax liability | 28,411,876 | 26,778,865 | |||||
Warrant liability | 9,968,000 | 9,345,000 | |||||
TOTAL LIABILITIES | 426,824,728 | 450,870,080 | |||||
COMMITMENTS AND CONTINGENCIES | |||||||
MEZZANINE EQUITY | |||||||
Series A convertible preferred stock, | 5,000,000 | — | |||||
TOTAL MEZZANINE EQUITY | 5,000,000 | — | |||||
STOCKHOLDERS' EQUITY | |||||||
Preferred stock, | — | — | |||||
Class A common stock, | 9,795 | 10,133 | |||||
Treasury stock - at cost; 6,129,703 and 1,048,260 shares repurchased at June 30, 2025 and December 31, 2024, respectively | (47,076,918 | ) | (12,025,137 | ) | |||
Additional paid-in capital | 499,438,543 | 494,064,113 | |||||
Accumulated deficit | (35,767,080 | ) | (57,896,606 | ) | |||
Noncontrolling interest | (71,148 | ) | (857,831 | ) | |||
TOTAL STOCKHOLDERS' EQUITY | 416,533,192 | 423,294,672 | |||||
TOTAL LIABILITIES, MEZZANINE EQUITY, AND STOCKHOLDERS' EQUITY | $ | 848,357,920 | $ | 874,164,752 | |||
ABACUS GLOBAL MANAGEMENT, INC. UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) | |||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||
REVENUES: | |||||||||||||||
Asset management fees | $ | 8,761,876 | $ | 204,888 | $ | 16,534,953 | $ | 422,823 | |||||||
Life solutions | 47,300,844 | 28,871,214 | 83,599,501 | 50,140,463 | |||||||||||
Technology services | 161,900 | — | 229,512 | — | |||||||||||
TOTAL REVENUES | 56,224,620 | 29,076,102 | 100,363,966 | 50,563,286 | |||||||||||
COST OF REVENUES (excluding depreciation and amortization stated below): | |||||||||||||||
Cost of revenue (including stock-based compensation) | 6,054,644 | 2,743,534 | 13,163,051 | 5,464,431 | |||||||||||
GROSS PROFIT | 50,169,976 | 26,332,568 | 87,200,915 | 45,098,855 | |||||||||||
OPERATING EXPENSES: | |||||||||||||||
Sales and marketing | 3,267,715 | 2,552,801 | 5,883,715 | 4,482,745 | |||||||||||
General and administrative (including stock-based compensation) | 18,926,329 | 14,553,344 | 31,190,115 | 25,906,843 | |||||||||||
(Gain) loss on change in fair value of debt | — | 1,199,463 | (3,362,103 | ) | 3,912,090 | ||||||||||
Unrealized loss (gain) on investments | 272,254 | 362,482 | — | (802,484 | ) | ||||||||||
Realized gain on investments | — | (856,744 | ) | — | (856,744 | ) | |||||||||
Depreciation and amortization expense | 5,184,083 | 1,750,452 | 9,942,629 | 3,432,506 | |||||||||||
TOTAL OPERATING EXPENSES | 27,650,381 | 19,561,798 | 43,654,356 | 36,074,956 | |||||||||||
OPERATING INCOME | 22,519,595 | 6,770,770 | 43,546,559 | 9,023,899 | |||||||||||
OTHER INCOME (EXPENSE): | |||||||||||||||
Gain (loss) on change in fair value of warrant liability | 4,183,000 | (667,500 | ) | (623,000 | ) | 279,460 | |||||||||
Interest expense | (8,752,145 | ) | (4,529,187 | ) | (18,370,475 | ) | (8,199,632 | ) | |||||||
Interest income | 1,012,278 | 639,906 | 2,187,279 | 1,061,332 | |||||||||||
Other income | 2,718,172 | 195,470 | 2,673,648 | 142,442 | |||||||||||
TOTAL OTHER EXPENSE | (838,695 | ) | (4,361,311 | ) | (14,132,548 | ) | (6,716,398 | ) | |||||||
NET INCOME BEFORE PROVISION FOR INCOME TAXES | 21,680,900 | 2,409,459 | 29,414,011 | 2,307,501 | |||||||||||
Income tax expense | 4,069,971 | 1,757,710 | 6,404,056 | 2,931,223 | |||||||||||
NET INCOME (LOSS) | 17,610,929 | 651,749 | 23,009,955 | (623,722 | ) | ||||||||||
LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST | 27,240 | (118,234 | ) | 786,683 | (44,960 | ) | |||||||||
NET INCOME (LOSS) ATTRIBUTABLE TO ABACUS GLOBAL MANAGEMENT, INC. | $ | 17,583,689 | $ | 769,983 | $ | 22,223,272 | $ | (578,762 | ) | ||||||
EARNINGS (LOSS) PER SHARE: | |||||||||||||||
Earnings (loss) per share - basic | $ | 0.18 | $ | 0.01 | $ | 0.23 | $ | (0.01 | ) | ||||||
Earnings (loss) per share - diluted | $ | 0.18 | $ | 0.01 | $ | 0.23 | $ | (0.01 | ) | ||||||
ABACUS GLOBAL MANAGEMENT, INC. ADJUSTED NET INCOME | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Net income (loss) attributable to Abacus Global Management | $ | 17,583,689 | $ | 769,983 | $ | 22,223,272 | $ | (578,762 | ) | |||||||
Net income (loss) attributable to noncontrolling interests | 27,240 | (118,234 | ) | 786,683 | (44,960 | ) | ||||||||||
Stock-based compensation | 3,486,829 | 6,165,459 | 5,842,224 | 12,258,830 | ||||||||||||
Business acquisition costs | 74,782 | 1,325,000 | 74,782 | 1,325,000 | ||||||||||||
Amortization expense | 4,667,987 | 1,706,033 | 9,301,141 | 3,388,117 | ||||||||||||
(Gain) loss on change in fair value of warrant liability | (4,183,000 | ) | 667,500 | 623,000 | (279,460 | ) | ||||||||||
Tax impact[1] | 233,137 | 1,178,552 | 233,137 | 2,344,454 | ||||||||||||
Adjusted Net Income | $ | 21,890,664 | $ | 11,694,293 | $ | 39,084,239 | $ | 18,413,219 | ||||||||
Weighted-Average Stock Outstanding - Basic | 94,690,195 | 63,846,170 | 95,437,545 | 63,087,878 | ||||||||||||
Weighted-Average Stock Outstanding - Diluted | 97,372,470 | 67,162,820 | 97,801,477 | 63,102,210 | ||||||||||||
Adjusted EPS - Basic | $ | 0.23 | $ | 0.18 | $ | 0.41 | $ | 0.29 | ||||||||
Adjusted EPS - Diluted | $ | 0.22 | $ | 0.17 | $ | 0.40 | $ | 0.29 | ||||||||
[1] Tax impact represents the permanent difference in tax expense related to the restricted stock awards granted to certain executives due to IRC 162(m) limitations. | ||||||||||||||||
ABACUS GLOBAL MANAGEMENT, INC. ADJUSTED EBITDA | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Net Income (Loss) | $ | 17,610,929 | $ | 651,749 | $ | 23,009,955 | $ | (623,722 | ) | |||||||
Depreciation and amortization expense | 5,184,083 | 1,750,452 | 9,942,629 | 3,432,506 | ||||||||||||
Income tax expense | 4,069,971 | 1,757,710 | 6,404,056 | 2,931,223 | ||||||||||||
Interest expense | 8,752,145 | 4,529,187 | 18,370,475 | 8,199,632 | ||||||||||||
Other income | (2,718,172 | ) | (195,470 | ) | (2,673,648 | ) | (142,442 | ) | ||||||||
Interest income | (1,012,278 | ) | (639,906 | ) | (2,187,279 | ) | (1,061,332 | ) | ||||||||
(Gain) loss on change in fair value of warrant liability | (4,183,000 | ) | 667,500 | 623,000 | (279,460 | ) | ||||||||||
Stock-based compensation | 3,486,829 | 6,165,459 | 5,842,224 | 12,258,830 | ||||||||||||
Business acquisition costs | 74,782 | 1,325,000 | 74,782 | 1,325,000 | ||||||||||||
Realized and Unrealized gain on investments | 272,254 | (494,262 | ) | — | (1,659,228 | ) | ||||||||||
Change in fair value of debt | — | 1,199,463 | (3,362,103 | ) | 3,912,090 | |||||||||||
Adjusted EBITDA | $ | 31,537,543 | $ | 16,716,882 | $ | 56,044,091 | $ | 28,293,097 | ||||||||
Total Revenue | $ | 56,224,620 | $ | 29,076,102 | $ | 100,363,966 | $ | 50,563,286 | ||||||||
Adjusted EBITDA Margin % | ||||||||||||||||
Net Income Margin % | - | |||||||||||||||
ABACUS GLOBAL MANAGEMENT, INC. ADJUSTED RETURN ON INVESTED CAPITAL (ROIC) | |||||||
For the Period Ended | For the Period Ended | ||||||
June 30, 2025 | June 30, 2024 | ||||||
Total Assets | $ | 848,357,920 | $ | 483,854,905 | |||
Less: | |||||||
Intangible assets, net | (71,392,006 | ) | (26,352,123 | ) | |||
Goodwill | (238,921,108 | ) | (139,930,190 | ) | |||
Current Liabilities | (140,178,035 | ) | (55,383,057 | ) | |||
Total Invested Capital | $ | 397,866,771 | $ | 262,189,535 | |||
Adjusted Net income | $ | 21,890,664 | $ | 11,694,293 | |||
Adjusted Annualized ROIC | 22.0% | 17.8% | |||||
ABACUS GLOBAL MANAGEMENT, INC. ADJUSTED RETURN ON EQUITY (ROE) | |||||||
For the Period Ended | For the Period Ended | ||||||
June 30, 2025 | June 30, 2024 | ||||||
Total Shareholder Equity | $ | 416,533,192 | $ | 256,849,488 | |||
Adjusted Net income | $ | 21,890,664 | $ | 11,694,293 | |||
Adjusted Annualized ROE | 21.0% | 18.2% | |||||
